Trial Profile
A Phase 2b, Randomized, Multi-Dose Efficacy,Safety Study of the Oral Factor Xa Inhibitor DU-176b Versus Enoxaparin Sodium for Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty (STARS J-2)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2018
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Enoxaparin sodium
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- Acronyms STARS J-2
- Sponsors Daiichi Sankyo Inc
- 30 May 2016 New source identified and integrated (Japan Pharmaceutical Information Center - Clinical Trials Information JapicCTI090827).
- 27 Sep 2010 New trial record